Do you want to read an article? Please log in or register.
Neuroretinal Layer Thinning on OCT Imaging and Hemoglobin A1c in Youth With Type 1 Diabetes
Retinal DiseasesFurther Publications
Related content
COMMENTED
Retinal Diseases
Early Worsening of Diabetic Retinopathy Following Initiation of Hybrid Closed-Loop/Automated Insulin Delivery Systems in Type 1 Diabetes: A Systematic Review and Structured Study-Level Synthesis
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Diabetes Obes Metab
Anson M, Iqbal A, Azmi S, Weston P, Hughes L, Choudhury M, Hughes DM, Zheng Y, Burgess PI, Alam U
doi: 10.1111/dom.71084
RECOMMENDED
Retinal Diseases
Glucagon-Like Peptide-1 Receptor Agonists and Risk of Systemic and Ocular Vascular Complications in Patients with Type 2 Diabetes and Diabetic Retinopathy
★ 3
Recommended by
Prof. emer. Dr Josef Flammer, Faculty Member
Am J Ophthalmol
Shah J, Makwana B, Panchal K, Patel V, Patel T, Khadke S, Verma A, Vivekanandan S, Kong Y, Upadhyay J, Dani SS, Ramsey KM, Ganatra S, Ramsey DJ
doi: 10.1016/j.ajo.2026.04.021
Retinal Diseases
Global temporal trends of DR-related blindness and vision loss from 1990 to 2021: an age-period-cohort analysis of the contributions of type 1 and type 2 diabetes
Br J Ophthalmol
Guan Z, Li Y, Li Y, Qian Z, Du Y, Yin S, Chen B, Wang H, Jiang J, Chen H, Congdon N, Qiu K
doi: 10.1136/bjo-2025-328581
Retinal Diseases
Glucagon-like peptide-1 receptor agonists and risk of diabetic retinopathy in type 2 diabetes: A systematic review and network meta-analysis of randomized clinical trials
Surv Ophthalmol
Ortiz-Seller A, Real JT, Morcillo E, Ortiz JL
doi: 10.1016/j.survophthal.2026.08.007
Retinal Diseases
30-Year Trends in Microvascular Complications and Treatment in Adolescents With Type 1 Diabetes
Diabetes Care
Calligaro LI, Liew G, Cho YH, Allen DW, Pryke A, Cusumano J, Chan A, Craig ME, Donaghue KC
doi: 10.2337/dc26-0388
Retinal Diseases
Looking Beyond Glycaemic Control: Real-World 12-Month Cardiometabolic and Retinopathy Outcomes Following Omnipod 5 Initiation in People With Type 1 Diabetes
Diabetes Obes Metab
McNally E, Goodman I, Morris R, Maliekkal J, Saeed D, Tan HW, Berry S, Elliott J, Iqbal A
doi: 10.1111/dom.71129
COMMENTED
Retinal Diseases
Ocular Outcomes with Tirzepatide Versus Glucagon-like Peptide-1 Receptor Agonists in Type 2 Diabetes
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Ophthalmol Retina
Hong AT, Lin F, Keenan JD, Stewart JM
doi: 10.1016/j.oret.2026.02.002
COMMENTED
Macular DiseasesRetinal Diseases
Potential eye disorders in people with and without Type 2 diabetes mellitus exposed to GLP-1 receptor agonists; an examination of the FAERS (FDA Adverse Event reporting System) database
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Am J Ophthalmol
Murray M, Schifano F, Chiappini S, Corkery JM, Guirguis A
doi: 10.1016/j.ajo.2025.12.015
Retinal Diseases
Type 2 diabetes and diabetic retinopathy in Finland during 2000-2017 based on nationwide survey and register data
Acta Ophthalmol
Purola P, Lahtela J, Sääksjärvi K, Koskinen S, Uusitalo H
doi: 10.1111/aos.70198